Key result
High-dose digoxin fails to alter serum IL-1beta and TNF-alpha levels despite significant drug accumulation.
Why the study?
The early effects of high doses of digoxin on the production of pro-inflammatory cytokines in heart muscle were not well understood.
Answers are grounded in this paper and cite their sources.
Early cytokine effects of high-dose digoxin in healthy dogs are hypothesis-generating; human HF trials needed before any clinical consideration.
BACKGROUND: Tumor necrosis factor (TNF)-alpha and interleukin (IL)-1beta are pro-inflammatory cytokines, causing myocardial dysfunction and a negative inotropic effect. The drugs used to treat heart failure affect the production of cytokines. Digoxin, on which this study was focused, is one of the drugs for the treatment of heart failure. AIM: The present study was designed to examine the early effects of high doses of digoxin on the production of cytokines in healthy dogs. METHODS: Digoxin was given parenterally to dogs at 0.15 mg/kg. IL-1beta and TNF-alpha production and levels of digoxin in the serum were measured 0, 12, 24, 48, and 72 h following administration of digoxin. RESULTS: As the levels of serum digoxin taken at 12, 24, 48, and 72 h of administration were considered significantly high compared with preceding values (p < 0.001), no notable change in serum IL-1beta and TNF-alpha levels was observed. CONCLUSIONS: These results suggest that high doses of digoxin do not cause a significant cytokine production in heart muscle in the early phase.
No takes yet. Share an insight, caveat, or question.
Dülger et al. (2002) studied Healthy. Digoxin vs. Baseline (0 h) was evaluated on Serum IL-1beta and TNF-alpha levels. High-dose digoxin did not notably change serum IL-1beta and TNF-alpha levels in healthy dogs over 72 hours despite elevated serum digoxin levels.
Synapse has enriched 10 related papers. Consider them for comparative context: